Literature DB >> 16182494

Assessment of the maturity-related brainstem functions reveals the heterogeneous phenotypes and facilitates clinical management of Rett syndrome.

Peter O O Julu1, Ingegerd Witt Engerström.   

Abstract

We have investigated whether brainstem assessment using the Neuro Scope could be used for objective and quantitative monitoring of early development and later progress in Rett syndrome. Brainstem features can be seen on bedside examination of Rett patients and are included in the International Scoring system. The following cardiovascular vital signs were recorded simultaneously in real-time: cardiac vagal tone (CVT), cardiac sensitivity to baroreflex (CSB), heart rate (HR), and mean arterial blood pressure (MAP) and respiratory vital signs: breathing rate and pattern, transcutaneous partial pressures of oxygen (pO(2)) and carbon dioxide (pCO(2)). We assessed the occipito-frontal head circumference (OFHC), height and body mass index (BMI). Results are from 72 patients with classical Rett syndrome studied at the Swedish National Rett Centre. Three cardiorespiratory phenotypes, designated Forceful, Feeble and Apneustic breathers were present in similar proportions in the Rett population but early development measured by OFHC and BMI differed. Height was not affected. Baseline levels of CVT and CSB also differed within the phenotypes indicating differences in parasympathetic activities. However, parasympathetic activity in the whole population was similar to that previously reported in Rett. Baseline levels of MAP and HR were similar across the phenotypes, consistent with previous reports of little effect of Rett disorder on baseline sympathetic tone. Adverse responses to opiate analgesics and hypocapnoeic attacks were unique to specific phenotypes. We recommend early characterisation of these phenotypes in the management of Rett syndrome. We conclude that classical Rett syndrome consists of heterogeneous clinical phenotypes with distinct cardiorespiratory states. Brainstem functions can be used to identify these and to monitor development and treatment, thereby facilitating clinical management.

Entities:  

Mesh:

Year:  2005        PMID: 16182494     DOI: 10.1016/j.braindev.2005.02.012

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  19 in total

Review 1.  Cardiac disease and Rett syndrome.

Authors:  M Acampa; F Guideri
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

2.  Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2-/y knockout mice.

Authors:  Georg M Stettner; Peter Huppke; Cornelia Brendel; Diethelm W Richter; Jutta Gärtner; Mathias Dutschmann
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

3.  Altered carbon dioxide metabolism and creatine abnormalities in rett syndrome.

Authors:  Nicky S J Halbach; Eric E J Smeets; Jörgen Bierau; Irene M L W Keularts; Guy Plasqui; Peter O O Julu; Ingegerd Witt Engerström; Jaap A Bakker; Leopold M G Curfs
Journal:  JIMD Rep       Date:  2011-09-28

4.  Autonomic dysfunction and sudden death in patients with Rett syndrome: a systematic review

Authors:  Jatinder Singh; Evamaria Lanzarini; Paramala Santosh
Journal:  J Psychiatry Neurosci       Date:  2020-05-01       Impact factor: 6.186

5.  Rett Syndrome.

Authors:  E E J Smeets; K Pelc; B Dan
Journal:  Mol Syndromol       Date:  2012-04-16

6.  Diurnal variation in autonomic regulation among patients with genotyped Rett syndrome.

Authors:  Michael Sean Carroll; Jan-Marino Ramirez; Debra E Weese-Mayer
Journal:  J Med Genet       Date:  2020-03-10       Impact factor: 6.318

Review 7.  Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth.

Authors:  David M Katz; Mathias Dutschmann; Jan-Marino Ramirez; Gérard Hilaire
Journal:  Respir Physiol Neurobiol       Date:  2009-04-24       Impact factor: 1.931

8.  Enhanced dense core granule function and adrenal hypersecretion in a mouse model of Rett syndrome.

Authors:  Thomas Ladas; Shyue-An Chan; Michael Ogier; Corey Smith; David M Katz
Journal:  Eur J Neurosci       Date:  2009-08-07       Impact factor: 3.386

9.  Autonomic cardiovascular control in methyl-CpG-binding protein 2 (Mecp2) deficient mice.

Authors:  John M Bissonnette; Sharon J Knopp; James Maylie; Tran Thong
Journal:  Auton Neurosci       Date:  2007-06-04       Impact factor: 3.145

10.  IGF1 as a Potential Treatment for Rett Syndrome: Safety Assessment in Six Rett Patients.

Authors:  Giorgio Pini; Maria Flora Scusa; Laura Congiu; Alberto Benincasa; Paolina Morescalchi; Ilaria Bottiglioni; Pietro Di Marco; Paolo Borelli; Ubaldo Bonuccelli; Andrea Della-Chiesa; Adriele Prina-Mello; Daniela Tropea
Journal:  Autism Res Treat       Date:  2012-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.